Cardiac Imaging: Page 263

Imaging tackles cardiac 'octopus pot' syndrome
By Shalmali Pal
SAN FRANCISCO - Until recently, takotsubo cardiomyopathy has been a specifically Japanese syndrome. But cases of this transient left ventricular apical ballooning are beginning to pop up in the U.S. Three presentations at the American College of Physicians (ACP) meeting focused on how imaging is being used to take a closer look at this condition, named after the Japanese fishing pot designed to catch octopus.
April 18, 2005
Agfa bids for Heartlab
By AuntMinnie.com staff writers
Continuing its bid to expand its presence in the healthcare IT market, Agfa HealthCare has reached an agreement to purchase cardiac image and information management firm Heartlab for $132.5 million in cash.
April 17, 2005
AuntMinnie.com Cardiac Imaging Radiology Insider
By Tracie L. Thompson
April 17, 2005
Boston Scientific gets FDA approval for Liberté stent
By AuntMinnie.com staff writers
Interventional device manufacturer Boston Scientific said that it has received Food and Drug Administration approval for its Liberté bare-metal coronary stent system.
April 13, 2005
Praise for 3D echo-guided beating-heart surgery in atrial defect closure
By Shalmali Pal
SAN FRANCISCO - Having shown the feasibility of real-time, 3D echocardiography-guided cardiac surgery without cardiopulmonary bypass, Boston-based surgeons tested the technique in atrial septum defect (ASD) closure. Dr. Yoshihiro Suematsu shared their results Wednesday at the American Association for Thoracic Surgery (AATS) meeting.
April 12, 2005
Medtronic begins Endeavor IV trial
By AuntMinnie.com staff writers
Medical device developer Medtronic said that enrollment has begun in its Endeavor IV clinical trial, the final phase of its Endeavor clinical program to be used in support of a Food and Drug Administration premarket approval (PMA) application.
April 12, 2005
Heartlab nets CE Mark
By AuntMinnie.com staff writers
Cardiac image management firm Heartlab has secured the CE Mark for its entire class of products.
April 12, 2005
Novadaq reports positive results for Spy system
By AuntMinnie.com staff writers
A study presented at the American Association for Thoracic Surgery meeting showed that Novadaq's Spy intraoperative fluorescent imaging system correctly identified 58% more coronary artery bypass grafts with technical problems than transit-time ultrasound flow measurement.
April 11, 2005
Lack of ischemic mitral regurgitation on postop echo doesn't preclude additional problems
By Shalmali Pal
SAN FRANCISCO - When coronary bypass surgery is performed, ischemic mitral regurgitation (IMR) must be addressed as this complication is associated with poor long-term survival. But the durability of valve repair for IMR is currently under fire, despite its popularity over replacement procedures. Unfortunately, good postoperative echocardiography results cannot guarantee that the patient will not experience IMR, according to surgeons from Canada.
April 11, 2005
Boston Scientific initiates Syntax trial
By AuntMinnie.com staff writers
Interventional device manufacturer Boston Scientific said that enrollment has begun in the Syntax clinical trial, which will compare the performance of drug-eluting stents with cardiac surgery in patients with coronary artery disease.
April 11, 2005
Adding SPECT to women's workup improves coronary risk assessment
By Jerry Ingram
Women with an intermediate or high risk of developing coronary heart disease may benefit from SPECT myocardial perfusion imaging in addition to the standard exercise tolerance tests, according to research presented at the 2005 American College of Cardiology (ACC) meeting in Orlando.
April 11, 2005
Abbott gets FDA OK for ZoMaxx trial
By AuntMinnie.com staff writers
Interventional device developer Abbott Laboratories of Abbott Park, IL, said it has received conditional approval from the Food and Drug Administration for an investigational device exemption (IDE) application for the ZoMaxx drug-eluting stent.
April 6, 2005
Previous Page
Page 263 of 325
Next Page